“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers.
John S. Scales, MD, a vascular and interventional specialist with Radiology Associates of Ocala in central Florida, has agreed to the terms, according to the state.
In new Neiman Health Policy Institute research, scientists explored the use of artificial intelligence to aid in diagnosing PE on CTPA, with “AI-informed radiologists" scoring high marks.
The TowerBrook Capital-backed breast imaging provider announced the latest openings on May 11, with new centers in Houston and Doylestown, Pennsylvania.
This leaves only about 18% of docs practicing in physician-owned settings as of Jan. 1, with corporations employing an additional 48,000-plus docs over the past two years.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
